CEFDINIR 300 MG CAPSULE
For 30 capsules
Pharmacies pay
$13.74 filed
30 × $0.45808 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$20.80 estimated
$13.74 + $2.06 (15%) + $5.00 fee per fill = $20.80
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CEFDINIR 300 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cefdinir.
FDA gives its dosage form as capsule and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals and Rising Pharma Holdings, Inc.
FDA’s Established Pharmacologic Class for it is Cephalosporin Antibacterial.
The NADAC file of 2026-10-14 prices it under 9 NDCs (National Drug Codes); the FDA directory lists 8 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $13.74 for 30 capsules (30 × $0.45808 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| American Health Packaging | 1 | $0.45808 per EA filed |
| Ascend Laboratories, LLC | 1 | $0.45808 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.45808 per EA filed |
| BluePoint Laboratories | 1 | $0.45808 per EA filed |
| Lupin Pharmaceuticals, Inc. | 1 | $0.45808 per EA filed |
| Major Pharmaceuticals | 1 | $0.45808 per EA filed |
| Rising Pharma Holdings, Inc. | 1 | $0.45808 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $0.45808 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.45808 per EA filed |
All 9 NDCs, with labeler and price
- 00093-3160-06 · Teva Pharmaceuticals USA, Inc. · $0.45808 per EA · eff. 2026-09-23 filed
- 00904-7563-04 · Major Pharmaceuticals · $0.45808 per EA · eff. 2026-09-23 filed
- 57237-0099-60 · Rising Pharma Holdings, Inc. · $0.45808 per EA · eff. 2026-09-23 filed
- 60687-0699-11 · not listed as a package in the FDA directory · $0.45808 per EA · eff. 2026-09-23 filed
- 60687-0699-21 · American Health Packaging · $0.45808 per EA · eff. 2026-09-23 filed
- 65862-0177-60 · Aurobindo Pharma Limited · $0.45808 per EA · eff. 2026-09-23 filed
- 67877-0543-60 · Ascend Laboratories, LLC · $0.45808 per EA · eff. 2026-09-23 filed
- 68001-0362-06 · BluePoint Laboratories · $0.45808 per EA · eff. 2026-09-23 filed
- 68180-0711-60 · Lupin Pharmaceuticals, Inc. · $0.45808 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share the FDA nonproprietary name cefdinir with CEFDINIR 300 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CEFDINIR 125 MG/5 ML SUSP | $0.10536 to $0.11131 per ML filed | We don’t know yet |
| CEFDINIR 250 MG/5 ML SUSP | $0.10999 to $0.11757 per ML filed | We don’t know yet |
| CEFDINIR 300 MG CAPSULE this page | $0.45808 per EA filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Compared with its class
The middle of its 9 NDCs’ NADAC prices is $0.45808 per EA filed.
Of the 20 other products in FDA’s Cephalosporin Antibacterial class priced per EA, 15 have a higher middle NADAC price and 5 a lower one. The one in the middle is CEFAZOLIN 1 GM VIAL, at $1.07031 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- CEFUROXIME AXETIL 250 MG TAB
- CEFAZOLIN 1 GM VIAL
- CEFTAZIDIME 1 GM VIAL
- CEFACLOR 250 MG CAPSULE
- CEFADROXIL 500 MG CAPSULE